These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35977581)

  • 21. Prophylactic catheter ablation for induced monomorphic ventricular tachycardia in patients with implantable cardioverter defibrillators as primary prevention.
    Hayashi T; Fukamizu S; Hojo R; Komiyama K; Tanabe Y; Tejima T; Soejima K; Nishizaki M; Hiraoka M; Ako J; Momomura S; Sakurada H
    Europace; 2013 Oct; 15(10):1507-15. PubMed ID: 23603305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radiofrequency catheter ablation of ventricular tachycardia in patients with an implantable defibrillator. Long-term follow-up].
    Cabrera AM; Cordero AB; Rodríguez JA; Carmona JR; de Teresa Galván E
    Rev Esp Cardiol; 2005 May; 58(5):491-8. PubMed ID: 15899194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation.
    Arya A; Eitel C; Bollmann A; Wetzel U; Sommer P; Gaspar T; Husser D; Piorkowski C; Hindricks G
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1312-8. PubMed ID: 20723092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic catheter ablation for the prevention of defibrillator therapy.
    Reddy VY; Reynolds MR; Neuzil P; Richardson AW; Taborsky M; Jongnarangsin K; Kralovec S; Sediva L; Ruskin JN; Josephson ME
    N Engl J Med; 2007 Dec; 357(26):2657-65. PubMed ID: 18160685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results.
    Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.
    Marchlinski FE; Haffajee CI; Beshai JF; Dickfeld TL; Gonzalez MD; Hsia HH; Schuger CD; Beckman KJ; Bogun FM; Pollak SJ; Bhandari AK
    J Am Coll Cardiol; 2016 Feb; 67(6):674-683. PubMed ID: 26868693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter-defibrillator therapy: influence of left ventricular function on long-term results.
    Pitschner HF; Neuzner J; Himmrich E; Liebrich A; Jung J; Heisel A
    J Interv Card Electrophysiol; 1997 Nov; 1(3):211-20. PubMed ID: 9869974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians.
    Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E
    Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): an on-treatment analysis.
    Delacrétaz E; Brenner R; Schaumann A; Eckardt L; Willems S; Pitschner HF; Kautzner J; Schumacher B; Hansen PS; Kuck KH;
    J Cardiovasc Electrophysiol; 2013 May; 24(5):525-9. PubMed ID: 23350967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unmappable ventricular tachycardia after an old myocardial infarction. Long-term results of substrate modification in patients with an implantable cardioverter defibrillator.
    Alzand BS; Timmermans CC; Wellens HJ; Dennert R; Philippens SA; Portegijs PJ; Rodriguez LM
    J Interv Card Electrophysiol; 2011 Aug; 31(2):149-56. PubMed ID: 21340515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Substrate Modification by Catheter Ablation on Implantable Cardioverter-Defibrillator Interventions in Patients With Unstable Ventricular Arrhythmias and Coronary Artery Disease: Results From the Multicenter Randomized Controlled SMS (Substrate Modification Study).
    Kuck KH; Tilz RR; Deneke T; Hoffmann BA; Ventura R; Hansen PS; Zarse M; Hohnloser SH; Kautzner J; Willems S;
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia; long-term outcome in relation to acute electrophysiological findings.
    Della Bella P; De Ponti R; Uriarte JA; Tondo C; Klersy C; Carbucicchio C; Storti C; Riva S; Longobardi M
    Eur Heart J; 2002 Mar; 23(5):414-24. PubMed ID: 11846499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ablation Outcomes and Predictors of Mortality Following Catheter Ablation for Ventricular Tachycardia: Data From the German Multicenter Ablation Registry.
    Tilz RR; Lin T; Eckardt L; Deneke T; Andresen D; Wieneke H; Brachmann J; Kääb S; Chun KRJ; Münkler P; Lewalter T; Hochadel M; Senges J; Kuck KH
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29572321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of catheter radiofrequency ablation for the treatment of ventricular arrhythmia storm post cardioverter-defibrillators implantation].
    Sun YM; Yu JB; Chen ML; Yang B; Zhang FX; Shen FR; Wang ZJ; Ju WZ; Chen HW; Lin YZ; Cao KJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):233-8. PubMed ID: 23879950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and safety of catheter ablation of electrical storm in ischemic dilated cardiomyopathy.
    Dello Russo A; Casella M; Pelargonio G; Santangeli P; Bartoletti S; Bencardino G; Al-Mohani G; Innocenti E; Di Biase L; Avella A; Pappalardo A; Carbucicchio C; Bellocci F; Fiorentini C; Natale A; Tondo C
    J Cardiovasc Med (Hagerstown); 2016 Jun; 17(6):425-32. PubMed ID: 25943625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators.
    Morawski S; Pruszkowska P; Sredniawa B; Lenarczyk R; Kalarus Z
    J Interv Card Electrophysiol; 2017 Dec; 50(3):227-234. PubMed ID: 29064045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Catheter ablation of ventricular tachycardia in patients with structural heart disease].
    Lindemann F; Darma A; Hindricks G
    Herz; 2022 Apr; 47(2):129-134. PubMed ID: 35262743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.